Tower Research Capital (TRC)’s UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In MLPS Stock Holding History
Bought
Maintained
Sold
Tower Research Capital (TRC)'s MLPS Position: Q2 2016 in Review
Tower Research Capital (TRC) sold out of UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In (MLPS) in Q2 2016, closing a stake of 100 shares — an estimated $2K sold.
Tower Research Capital (TRC) first reported a position in MLPS in Q4 2015 and held it in 2 quarters. The position peaked at $2K in Q1 2016. 1 fund tracked by Wall St. Rank holds MLPS as of Q2 2016.
- Tower Research Capital (TRC) reported no remaining UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In position as of Q2 2016 after selling out during the quarter.
- Tower Research Capital (TRC) sold 100 UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In shares in Q2 2016, an estimated $2K.
- Tower Research Capital (TRC) first reported a position in UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In in Q4 2015 and held it in 2 quarters.
- Tower Research Capital (TRC)'s UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In position peaked at $2K in Q1 2016.
- 1 fund tracked by Wall St. Rank held UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In as of Q2 2016.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.